• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[去苯丙氨酸胰岛素的长期治疗]

[Long-term treatment with Des-Phe-Insulin].

作者信息

Hirn S, Pietschmann H

出版信息

Wien Klin Wochenschr. 1982 Dec 24;94(24):662-5.

PMID:6820587
Abstract

At a geriatric department 61 insulin-dependent diabetics have been treated with des-phe-insulin (DPI) for periods of up to 6 years since 1976. The use of either pure DPI, amorphous DPI or DPI mixed with varying amounts of crystalline non-modified insulin of the same species allowed flexible longterm therapy, as well as management of metabolic emergencies. Comparison of the doses needed before and after change to and from other insulin preparations showed no difference in efficacy. No side effects of such severity as to necessitate interruption of therapy were observed.

摘要

自1976年以来,在一家老年病科,61名胰岛素依赖型糖尿病患者接受了去苯丙氨酸胰岛素(DPI)治疗,治疗时间长达6年。使用纯DPI、无定形DPI或与不同量相同物种的结晶非修饰胰岛素混合的DPI,既可以进行灵活的长期治疗,也可以处理代谢急症。与换用其他胰岛素制剂前后所需剂量相比,疗效无差异。未观察到严重到需要中断治疗的副作用。

相似文献

1
[Long-term treatment with Des-Phe-Insulin].[去苯丙氨酸胰岛素的长期治疗]
Wien Klin Wochenschr. 1982 Dec 24;94(24):662-5.
2
[Are des-Phe-insulin-containing insulin combinations preferable to regular trade preparations?].含去苯丙氨酸胰岛素的胰岛素组合是否比常规商业制剂更具优势?
Med Klin. 1981 May 22;76(11):319-23.
3
Clinical trial with porcine des-Phe B1 insulin. A comparative study with unmodified insulin on therapeutical efficacy, biological activity and immunogenicity.
Diabete Metab. 1981 Sep;7(3):173-9.
4
[Treatment of diabetes without biguanides. Observation on the course after changing treatment (author's transl)].
MMW Munch Med Wochenschr. 1979 Aug 31;121(35):1109-12.
5
[Experiences with a chemically modified monospecies-insulin].
Med Klin. 1981 Aug 14;76(17):479-81.
6
[Behavior of lactate and pyruvate in diabetics treated with a combination of fenformin and sulfonylurea in varying doses. I].
Clin Ter. 1980 Jun 15;93(5):525-33.
7
[Preliminary clinical experiences and problems of long-term therapy of diabetes mellitus using 2nd generation sulfonylurea derivatives (glibenclamide)].[使用第二代磺酰脲类衍生物(格列本脲)治疗糖尿病的初步临床经验及长期治疗问题]
Z Gesamte Inn Med. 1973 May 15;28(10):Suppl 10:149-5.
8
Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.胰岛素与磺脲类药物联合治疗II型糖尿病的疗效:随机安慰剂对照试验的荟萃分析
Arch Intern Med. 1996 Feb 12;156(3):259-64.
9
[Interference of clofibrate in metabolic compensation in dyslipidemic diabetics].[氯贝丁酯对血脂异常糖尿病患者代谢代偿的干扰作用]
Clin Ter. 1979 Oct 15;91(1):57-65.
10
[Results of long-term therapy of diabetes mellitus using sulfonylurea compounds].[使用磺脲类化合物对糖尿病进行长期治疗的结果]
Z Gesamte Inn Med. 1973 May 15;28(10):Suppl 10:153-4.